
Agile Medical Technology unveils Agibot endoscopic surgical robot system
Agile Medical Technology today took to social media to introduce its Agibot Endoscopic Surgical System, a surgical robotic platform for endoscopic procedures.
Agile Medical Technology today took to social media to introduce its Agibot Endoscopic Surgical System, a surgical robotic platform for endoscopic procedures.
TELFORD, Pa., Aug. 11, 2025 /PRNewswire/ — Today Dräger, an international leader in medical and safety technologies, announced that the company’s Atlan A350/A350 XL series of anesthesia workstations received Authority to Operate (ATO) certification under the Department of Defense’s (DoD) Risk Management Framework (RMF) eMASS #4060.
Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or expand manufacturing sites in the U.S.
PLANO, Texas, Aug. 7, 2025 /PRNewswire/ — ulrich medical USA, a leading medical device company focused on developing and commercializing spinal implant technologies, is proud to announce the full market launch of the Cortium® Universal OCT Spinal Fixation System, following a successful alpha release.
Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in the U.S.
TWINSBURG, Ohio, July 15, 2025 /PRNewswire/ — Edgepark has recently expanded its portfolio to include the latest innovations from diabetes manufacturers, including the first-ever FDA-cleared yearlong continuous glucose monitor (CGM) system, and a glucose biosensor that can be purchased without a prescription.
New imaging innovation enhances wound assessment by combining fluorescence and thermal data for improved diagnostic precision and patient care
Sequel Med Tech announced at the American Diabetes Association’s 85th Scientific Sessions in Chicago that it plans to launch its twiist system in July.
Next-gen portable ultrasound system combines speed, image clarity, and AI-powered tools to elevate diagnostic confidence at the bedside.
New leadership and AI-driven technology aim to revolutionize assessment and care for brain-related conditions